Cancer can affect any part of the body, but brain tumors are among the most debilitating forms of the disease. In the United States alone, approximately 80,000 new cases of brain tumors are reported annually, with around 25,000 of these being particularly aggressive. One of the deadliest types of brain cancer is caused by cells known as glioblastomas, or GBMs.
In a groundbreaking development, scientists have introduced a new treatment for GBM brain cancer, presenting hope for many patients. This treatment involves a cap called Optune, which emits tumor-treating fields—electrical fields designed to inhibit cancer cell growth. Optune has been shown to extend the lifespan of brain tumor patients and reduce premature deaths. The cap works by emitting low-frequency electrical energy that disrupts the rapid division and multiplication of GBM cancer cells.
The results of initial trials for Optune were presented in March 2017 at the American Association of Cancer Research’s annual meeting. The study included two groups of patients: one received only chemotherapy, while the other used Optune alongside chemotherapy. The results were significant, with the Optune group showing a much higher survival rate compared to those who received only chemotherapy.
Optune resembles a swimming cap and can be worn throughout the day, allowing patients to go about their daily activities. To maintain privacy and avoid curious stares, patients can wear a hat or wig over the cap.
Dr. Roger Stupp, leading the research team at the Feinberg School of Medicine, Northwestern University, Chicago, expressed optimism about the potential of Optune. He highlighted that the cap enhances traditional treatments, which typically include radiation followed by 6-12 months of chemotherapy.
Despite some medical practitioners viewing the cap as unconventional, the underlying science is straightforward. Research has demonstrated that cancer cells are negatively affected by specific electrical frequencies, which hinder their ability to reproduce and function, while healthy cells remain unaffected.
However, the high cost of the treatment—around USD 700 per day—poses a challenge for many patients. Additionally, there are some side effects, such as blood count issues, weakness, fatigue, and skin irritation from the electrodes.
While Optune may not be a cure for GBM brain cancer, it offers patients several extra months of life, which can be invaluable to them and their families. The ongoing battle against cancer continues, and there is hope that new treatments or combinations will eventually lead to a cure. The team behind Optune is committed to refining the technology to better meet the needs of patients and medical professionals, with the possibility of expanding its application to treat other types of cancer in the future.
Gentle Reminder: The information provided in this article is not a substitute for professional medical advice. Always seek the guidance of a qualified healthcare provider with any questions you may have regarding a medical condition.
Featured Image by freepik
Leave a Reply